succession
AbbVie’s New CEO Rob Michael Earns $18.5M in First Year as Humira Succession Plan Unfolds
AbbVie CEO succession, Rob Michael compensation, Humira patent expiration, Skyrizi and Rinvoq growth, Pharmaceutical executive pay
Julie Kim to Succeed Christophe Weber as Takeda’s CEO in 2026
Takeda, Julie Kim, Christophe Weber, CEO succession, pharmaceutical industry, leadership transition, biopharmaceutical company